Non Hodgkin Lymphoma News and Research

RSS
Meta-analysis of glyphosate-based plant protection products and NHL involves uncertainty

Meta-analysis of glyphosate-based plant protection products and NHL involves uncertainty

Popular weed killer’s alleged link to cancer spreads concern

Popular weed killer’s alleged link to cancer spreads concern

Study reveals investigational drug as effective treatment for relapsed marginal zone lymphoma

Study reveals investigational drug as effective treatment for relapsed marginal zone lymphoma

Common herbicide found to increase the risk of Non-Hodgkin Lymphoma

Common herbicide found to increase the risk of Non-Hodgkin Lymphoma

Exposure to chemical in weedkiller Roundup raises risk of some cancers, study finds

Exposure to chemical in weedkiller Roundup raises risk of some cancers, study finds

Cancer among Israeli men on the decline says report

Cancer among Israeli men on the decline says report

Risk of heart attack and stroke is high in the months before cancer diagnosis, shows study

Risk of heart attack and stroke is high in the months before cancer diagnosis, shows study

Study: 39% of B cell lymphoma patients treated with CAR T therapy remain in remission

Study: 39% of B cell lymphoma patients treated with CAR T therapy remain in remission

Scientists use genetically engineered immune cells to fight Hodgkin and non-Hodgkin lymphoma cells

Scientists use genetically engineered immune cells to fight Hodgkin and non-Hodgkin lymphoma cells

Amgen announces presentation of new clinical data showcasing early oncology pipeline at ASH 2018

Amgen announces presentation of new clinical data showcasing early oncology pipeline at ASH 2018

Head and neck cancer survivors more likely to commit suicide

Head and neck cancer survivors more likely to commit suicide

Organic food may protect against cancers finds study

Organic food may protect against cancers finds study

Phase 3 ECHELON-2 clinical trial evaluating ADCETRIS plus CHP meets primary endpoint

Phase 3 ECHELON-2 clinical trial evaluating ADCETRIS plus CHP meets primary endpoint

Verastem Oncology selects US Bioservices to dispense COPIKTRA capsules

Verastem Oncology selects US Bioservices to dispense COPIKTRA capsules

FDA lifts partial clinical hold that paused enrollment of new patients in tazemetosta clinical trials

FDA lifts partial clinical hold that paused enrollment of new patients in tazemetosta clinical trials

Study reveals how socioeconomic status affects racial, ethnic disparities in childhood cancer survival

Study reveals how socioeconomic status affects racial, ethnic disparities in childhood cancer survival

Hospitals battle for control over fast-growing heart-valve procedure

Hospitals battle for control over fast-growing heart-valve procedure

FDA approves drug for rare, hard-to-treat types of non-Hodgkin lymphoma

FDA approves drug for rare, hard-to-treat types of non-Hodgkin lymphoma

AbbVie submits supplemental NDA to FDA for venetoclax to treat acute myeloid leukemia

AbbVie submits supplemental NDA to FDA for venetoclax to treat acute myeloid leukemia

CTI BioPharma announces Phase III results of PIXUVRI combined with rituximab in aggressive B-cell NHL patients

CTI BioPharma announces Phase III results of PIXUVRI combined with rituximab in aggressive B-cell NHL patients